The global Personalized Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patients particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Vaccines. This report contains market size and forecasts of Personalized Cancer Vaccines in global, including the following market information:
Global Personalized Cancer Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cancer Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Personalized Cancer Vaccines include Advaxis Inc, Personalis, Hoffmann-La Roche Ltd, BioNtech, Celldex, CureVac AG, Genetech, Genocea and Gritstone Oncology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Cancer Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
- By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Prostate Cancer
- Cervical Cancer
- Glioblastoma
- Others
- By Mechanism of Action Type
- Tumor-associated antigens (TAAs)
- Tumor-specific antigens (TSAs)
- Somatic Mutations in Cancer Pharmacogenomics
- Pharmacogenomics towards Genomic Polymorphism
Global Personalized Cancer Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Homecare
- Specialty Clinics
- Others
Global Personalized Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Personalized Cancer Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Personalized Cancer Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Advaxis Inc
- Personalis
- Hoffmann-La Roche Ltd
- BioNtech
- Celldex
- CureVac AG
- Genetech
- Genocea
- Gritstone Oncology
- ISA Pharmaceuticals
- Merck
- Moderna Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Cancer Vaccines, market overview.
Chapter 2: Global Personalized Cancer Vaccines market size in revenue.
Chapter 3: Detailed analysis of Personalized Cancer Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
